rhodioloside has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, H; Kang, J; Yin, Y; Zhang, D; Zheng, R | 1 |
| Cai, X; Cao, L; Feng, H; Kang, J; Li, M; Wang, W; Wang, Z; Xu, M; Yin, Y; Yu, N; Zhang, D | 1 |
| Liu, J; Luo, F; Miao, M; Yan, T | 1 |
3 other study(ies) available for rhodioloside and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Salidroside ameliorated the pulmonary inflammation induced by cigarette smoke via mitigating M1 macrophage polarization by JNK/c-Jun.
Topics: Animals; Cigarette Smoking; Cytokines; Emphysema; Lung; Macrophages; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Wistar | 2023 |
Salidroside mitigates skeletal muscle atrophy in rats with cigarette smoke-induced COPD by up-regulating myogenin and down-regulating myostatin expression.
Topics: Animals; Antioxidants; Disease Models, Animal; Down-Regulation; Glucosides; Lung; Male; Muscle, Skeletal; Muscular Atrophy; Myogenin; Myostatin; Nicotiana; Phenols; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Wistar; Smoke; Smoking; Up-Regulation | 2019 |
Salidroside alleviates cigarette smoke-induced COPD in mice.
Topics: Animals; Dose-Response Relationship, Drug; Glucosides; Lung; Male; Mice; Mice, Inbred ICR; NF-kappa B; Phenols; Pulmonary Disease, Chronic Obstructive; Random Allocation; Smoking; Tumor Necrosis Factor-alpha | 2017 |